Dermata Therapeutics Inc (DRMA)

$1.22 -0.02 (-1.61%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	4.91M
Revenue (ttm)	0.00
Net Income (ttm)	-7.56M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	31,184
Avg Vol	1,003,570
Day's Range	N/A - N/A
Shares Out	4.02M
Stochastic %K	19%
Beta	0.67
Analysts	Strong Sell
Price Target	$4.00

Company Profile

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 858 800 2543

Website: www.dermatarx.com

Address:

3525 Del Mar Heights Rd., Suite 332, San Diego, United States

NotHopeJustFacts May. 12 at 2:55 PM

$BYND $AIXI sure, cause you're such a winner LMAO, it seems you do have a fetish for being a LOSER, POS like Beyond needs more bagholders like you, so bring your friends please so they can keep buying more of this Turd and maybe some more $DRMA LOL

0 · Reply

HolEKa1010 May. 8 at 7:02 PM

$DRMA

0 · Reply

brallt May. 1 at 2:48 PM

$DRMA Shorts have a strong interest in preventing 1.40-1.60+ price action to print on the daily. when zero sells are coming in around the 1mth high. within a building low volume uptrend off exausted sellers. Shorts pay a premium for sideways price action. (hopfully we can antaganize some shorts to provide us nice market buy adds)

0 · Reply